GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,419.60p
   
  • Change Today:
    -3.80p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.68m
  • Volume: 32,406,227
  • Market Cap: £58,128m
  • RiskGrade: 129

Regulatory News

Director/PDMR Shareholding 01-Feb-2023 15:30 RNS
Total Voting Rights 01-Feb-2023 15:00 RNS
Benlysta granted Orphan Drug Designation by US FDA 01-Feb-2023 07:05 RNS
Final Results 01-Feb-2023 07:00 RNS
Director/PDMR Shareholding 18-Jan-2023 15:30 RNS
Director/PDMR Shareholding 17-Jan-2023 15:30 RNS
Director/PDMR Shareholding 16-Jan-2023 15:30 RNS
Director/PDMR Shareholding 13-Jan-2023 15:30 RNS
Director/PDMR Shareholding 12-Jan-2023 15:30 RNS
Total Voting Rights 03-Jan-2023 15:00 RNS
Director/PDMR Shareholding 22-Dec-2022 15:30 RNS
Director/PDMR Shareholding 21-Dec-2022 15:35 RNS
Director/PDMR Shareholding 21-Dec-2022 15:30 RNS
Board and Committee Changes 15-Dec-2022 15:30 RNS
Director/PDMR Shareholding 13-Dec-2022 15:30 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,419.60p
Change Today -3.80p
% Change -0.27 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 32,406,227
Shares Issued 4,094.68m
Market Cap £58,128m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.49% above the market average83.49% above the market average83.49% above the market average83.49% above the market average83.49% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
51.48% below the market average51.48% below the market average51.48% below the market average51.48% below the market average51.48% below the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average
Income
66.27% above the market average66.27% above the market average66.27% above the market average66.27% above the market average66.27% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
78.47% below the market average78.47% below the market average78.47% below the market average78.47% below the market average78.47% below the market average
95% below the sector average95% below the sector average95% below the sector average95% below the sector average95% below the sector average

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 15
Sell 1
Strong Sell 1
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 01-Feb-2023

Time Volume / Share Price
10:04 6,324,027 @ 1,438.20p
16:47 6,390,027 @ 1,438.20p
10:04 6,324,027 @ 1,438.20p
16:47 6,390,027 @ 1,438.20p
17:07 2,000 @ 1,443.11p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page